Glipizide Tablet
Product Images NDC 51655-810

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655 810 25 Master Bottle Label Approval Rev A 07 20

Glipizide Tablets USP 10 mg oral tablets label showing a 60-tablet package from Northwind Health Company, LLC. The label includes dosage form, strength, quantity, NDC 51655-810-25, and storage instructions to keep below 30°C (86°F). It is marked Rx only and advises to keep out of reach of children.*

FDA Label Image

Image 1

Chemical structure diagram of Glipizide, showing its molecular framework with characteristic rings and functional groups, corresponding to the active ingredient Glipizide in tablet form by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.